管理
• 文章

From pioneer to expert: Dr CS Ho’s journey in the evolution of clinical mass spectrometry

Dr Chung Shun “CS” Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to the evolved, integrated machinery it is today. When he first started at The Chinese University of Hong Kong, Dr Ho has been at the helm of working with mass spectrometry since its introduction to the university. Years of experimenting with it has led to discoveries in better testing techniques, analysis with upgraded accompanying software, and laboratory workflows. Improving skills in mass spectrometry is only one part of it, Dr Ho also enjoys that community of like-minded researchers and professionals he has encountered in this journey of clinical mass spectrometry.
Star

閱讀清單

所有類別
  • 所有類別
  • 疾病領域
  • 特定展會
  • 管理
  • 營運
疾病領域
• 文章

Why early CSF testing is a game-changer for Alzheimer’s disease in China

疾病領域
• 文章

Beyond the bite: why blood transfusion safety matters amidst the global dengue surge

營運
• 文章

Co-creating change beyond the machine: why effective total lab automation starts with its people

疾病領域
• 文章

Why expanding access to accurate dengue tests is a critical need in Asia

ProjectorScreen

熱門內容

hcv
疾病領域
• 文章
The practical benefits of HCV antigen-antibody dual assay: Q&A with Prof Tawesak Tanwandee
Bridging the quality gap in digital pathology from pre analytics to AI QA with Dr Kunal Sharma
管理
• 文章
AI作為現代數位病理學的基本副駕駛：與Kunal Sharma博士進行問答
特定展會
• 文章
國際乳突病毒學會(IPVS 2025)第37屆年會的主要收穫
特定展會
• 文章
數位給藥與治療藥物監測的未來：第23屆IATDMCT大會的見解

醫療社群

更多關於撰稿人的資訊>

醫療社群

更多關於撰稿人的資訊>
篩選器

更多關於撰稿人的資訊>
Scroll to Top